Type I interferon production enhances susceptibility to Listeria monocytogenes infection

Journal of Experimental Medicine

Volumn 200, Issue 4, 2004, Pages 437-445

  O'Connell, Ryan M ^a   Saha, Supriya K ^a   Vaidya, Sagar A ^a   Bruhn, Kevin W ^a   Miranda, Gustavo A ^a,b   Zarnegar, Brian ^a   Perry, Andrea K ^a   Nguyen, Bidong O ^a   Lane, Timothy F ^a,b   Taniguchi, Tadatsugu ^c   Miller, Jeff F ^a   Cheng, Genhong ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Apoptosis; IFN target gene; IFNAR; Intracellular bacteria; IRF3

Indexed keywords

BETA INTERFERON; INTERFERON; INTERFERON RECEPTOR; INTERFERON REGULATORY FACTOR 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HOST SUSCEPTIBILITY; IMMUNOMODULATION; INFECTION SENSITIVITY; INTERFERON PRODUCTION; LISTERIA MONOCYTOGENES; LISTERIOSIS; MOUSE; NICK END LABELING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; DISEASE SUSCEPTIBILITY; DNA PRIMERS; DNA-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; IN SITU NICK-END LABELING; INTERFERON REGULATORY FACTOR-3; INTERFERON TYPE I; LISTERIA INFECTIONS; LIVER; MACROPHAGES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; POLYMERASE CHAIN REACTION; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, INTERFERON; SPLEEN; TRANSCRIPTION FACTORS;

EID: 4344627833     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20040712     Document Type: Article

References (33)

1. Isaacs, A., and J. Lindenmann. 1957. Virus interference. I. The interferon. Proc. R. Soc. Lond. B. Biol. Sci. 147:258-267.
2. Taniguchi, T., and A. Takaoka. 2002. The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr. Opin. Immunol. 14:111-116.
3. Le Bon, A., and D.F. Tough. 2002. Links between innate and adaptive immunity via type I interferon. Curr. Opin. Immunol. 14:432-436.
4. Biron, C.A. 2001. Interferons alpha and beta as immune regulators-a new look. Immunity. 14:661-664.
5. Taniguchi, T., K. Ogasawara, A. Takaoka, and N. Tanaka. 2001. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19:623-655.
6. Doyle, S., S. Vaidya, R. O'Connell, H. Dadgostar, P. Dempsey, T. Wu, G. Rao, R. Sun, M. Haberland, R. Modlin, et al. 2002. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity. 17:251-263.
7. Doyle, S.E., R. O'Connell, S.A. Vaidya, E.K. Chow, K. Yee, and G. Cheng. 2003. Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4. J. Immunol. 170:3565-3571.
8. Kawai, T., O. Takeuchi, T. Fujita, J. Inoue, P.F. Muhlradt, S. Sato, K. Hoshino, and S. Akira. 2001. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167:5887-5894.
9. Sakaguchi, S., H. Negishi, M. Asagiri, C. Nakajima, T. Mizutani, A. Takaoka, K. Honda, and T. Taniguchi. 2003. Essential role of IRF-3 in lipopolysaccharide-induced interferon-beta gene expression and endotoxin shock. Biochem. Biophys. Res. Commun. 306:860-866.
10. Akira, S. 2003. Mammalian Toll-like receptors. Curr. Opin. Immunol. 15:5-11.
11. Wilson, C.B., and D.B. Lewis. 1990. Basis and implications of selectively diminished cytokine production in neonatal susceptibility to infection. Rev. Infect. Dis. 12:S410-S420.
12. Unanue, E.R. 1997. Studies in listeriosis show the strong symbiosis between the innate cellular system and the T-cell response. Immunol. Rev. 158:11-25.
13. Wing, E.J., and S.H. Gregory. 2002. Listeria monocytogenes: clinical and experimental update. J. Infect. Dis. 185:S18-S24.
14. Cossart, P. 2002. Molecular and cellular basis of the infection by Listeria monocytogenes: an overview. Int. J. Med. Microbiol. 291:401-409.
15. O'Riordan, M., C.H. Yi, R. Gonzales, K.D. Lee, and D.A. Portnoy. 2002. Innate recognition of bacteria by a macrophage cytosolic surveillance pathway. Proc. Natl. Acad. Sci. USA. 99:13861-13866.
16. Stockinger, S., T. Materna, D. Stoiber, L. Bayr, R. Steinborn, T. Kolbe, H. Unger, T. Chakraborty, D.E. Levy, M. Muller, and et al. 2002. Production of type I IFN sensitizes macrophages to cell death induced by Listeria monocytogenes. J. Immunol. 169:6522-6529.
17. Havell, E.A. 1986. Augmented induction of interferons during Listeria monocytogenes infection. J. Infect. Dis. 153:960-969.
18. Chin, A.I., P.W. Dempsey, K. Bruhn, J.F. Miller, Y. Xu, and G. Cheng. 2002. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature. 416:190-194.
19. Sato, M., H. Suemori, N. Hata, M. Asagiri, K. Ogasawara, K. Nakao, T. Nakaya, M. Katsuki, S. Noguchi, N. Tanaka, et al. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity. 13:539-548.
20. Edelson, B.T., and E.R. Unanue. 2002. MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity. J. Immunol. 169:3869-3875.
21. Seki, E., H. Tsutsui, N.M. Tsuji, N. Hayashi, K. Adachi, H. Nakano, S. Futatsugi-Yumikura, O. Takeuchi, K. Hoshino, S. Akira, et al. 2002. Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice. J. Immunol. 169:3863-3868.
22. van den Broek, M.F., U. Muller, S. Huang, R.M. Zinkernagel, and M. Aguet. 1995. Immune defence in mice lacking type I and/or type II interferon receptors. Immunol. Rev. 148:5-18.
23. Muller, U., U. Steinhoff, L.F. Reis, S. Hemmi, J. Pavlovic, R.M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science. 264: 1918-1921.
24. Mattei, F., G. Schiavoni, F. Belardelli, and D.F. Tough. 2001. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J. Immunol. 167:1179-1187.
25. Decker, T., S. Stockinger, M. Karaghiosoff, M. Muller, and P. Kovarik. 2002. IFNs and STATs in innate immunity to microorganisms. J. Clin. Invest. 109:1271-1277.
26. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R.M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-gamma receptor. Science. 259:1742-1745.
27. Fehr, T., G. Schoedon, B. Odermatt, T. Holtschke, M. Schneemann, M.F. Bachmann, T.W. Mak, I. Horak, and R.M. Zinkernagel. 1997. Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis. J. Exp. Med. 185:921-931.
28. Clemens, M.J. 2003. Interferons and apoptosis. J. Interferon Cytokine Res. 23:277-292.
29. Merrick, J.C., B.T. Edelson, V. Bhardwaj, P.E. Swanson, and E.R. Unanue. 1997. Lymphocyte apoptosis during early phase of Listeria infection in mice. Am. J. Pathol. 151:785-792.
30. Jiang, J., L.L. Lau, and H. Shen. 2003. Selective depletion of nonspecific T cells during the early stage of immune responses to infection. J. Immunol. 171:4352-4358.
31. Carrero, J.A., B. Calderon, and E.R. Unanue. 2004. Listeriolysin O from Listeria monocytogenes is a lymphocyte apoptogenic molecule. J. Immunol. 172:4866-4874.
32. Auerbuch, V., D.G. Brockstedt, N. Meyer-Morse, M. O'Riordan, and D.A. Portnoy. 2004. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J. Exp. Med. 200:527-533.
33. Manca, C., L. Tsenova, A. Bergtold, S. Freeman, M. Tovey, J.M. Musser, C.E. Barry III, V.H. Freedman, and G. Kaplan. 2001. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta. Proc. Natl. Acad. Sci. USA. 98:5752-5757.